SLC9A3

Chr 5AR

solute carrier family 9 member A3

Plasma membrane Na(+)/H(+) antiporter (PubMed:18829453, PubMed:26358773, PubMed:35613257). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry, playing a key role in salt and fluid absorption and pH homeostasis (By similarity). Major apical Na(+)/H(+) exchanger in kidney and intestine playing an important role in renal and intestine Na(+) absorption and blood pressure regulation (PubMed:24622516, PubMed:26358773)

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.311 OMIM phenotype
Clinical SummarySLC9A3
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 153 VUS of 365 total submissions
Some data sources returned errors (1)

ncbi: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.31LOEUF
pLI 0.978
Z-score 4.83
OE 0.16 (0.090.31)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.49Z-score
OE missense 0.69 (0.640.76)
365 obs / 525.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.16 (0.090.31)
00.351.4
Missense OE?0.69 (0.640.76)
00.61.4
Synonymous OE?1.17
01.21.6
LoF obs/exp: 6 / 38.2Missense obs/exp: 365 / 525.7Syn Z: -2.05

This gene — mechanism propensity

DN
0.6647th %ile
GOF
0.76top 25%
LOF
0.50top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF65% of P/LP variants are LoF · LOEUF 0.31
GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

365 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic4
VUS153
Likely Benign136
Benign32
Conflicting8
13
Pathogenic
4
Likely Pathogenic
153
VUS
136
Likely Benign
32
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
4
1
0
13
Likely Pathogenic
3
1
0
0
4
VUS
2
146
5
0
153
Likely Benign
0
8
51
77
136
Benign
0
3
15
14
32
Conflicting
8
Total131627291346

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

111 pathogenic / likely-pathogenic (of 142) ClinVar copy-number / structural variants overlap SLC9A3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SLC9A3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →